European Disease Progression Monitor: Edition 2

disease progression monitor in the EU for COVID-19

COVID-19 effects on the disease on services, systems and therapies

tracking the pandemic focused on evolution of the death rate

rate of growth for deaths due to COVID-19 in EU5 countries

risk for second cycle of COVID-19 infections

COVID-19 patient management focus

treatment and preventative therapies for COVID-19

testing rate variations on COVID-19

COVID-19 disease progression monitor disclaimer

For more information, please visit lek.com/covid19 or fill out this form to get in touch.

Other insights in this series:

European Disease progression monitor: Edition I
European Disease progression monitor: Edition III

Related Insights

Executive Insights

Life Sciences & Pharma

Refining Gross-to-Net Expectations for Improved Strategic Planning

November 4, 2024

Published Articles

Data & Analytics

Use Data and Analytics to Create Your Strategy, Not Just Drive It: Why Critical Decisions…

July 23, 2024

Video / Webinar

Healthcare Services

APAC's Booming Healthcare Data Monetization Market

July 18, 2024

Video / Webinar

Digital

How Digital Can Future Proof Your Business

June 1, 2024

Mergers & Acquisitions

Mergers and Acquisitions in Latin America: Evolution and Prospects

May 13, 2024

Executive Insights

Life Sciences & Pharma

Research Tools and Diagnostics: Outlook and Industry Trends in 2024

March 14, 2024